Skip to main content

RT @RichardPAConway: Tuttle et al. Phase 2 RCT of Peresolimab (PD-1 stimulator) in DMARD-IR RA. Evidence of efficacy. No

Nov 14, 2022 10:04 am
Social Author Name
Richard Conway
Tweet Content
Tuttle et al. Phase 2 RCT of Peresolimab (PD-1 stimulator) in DMARD-IR RA. Evidence of efficacy. No new safety signals @RheumNow #ACR22 Abstr#L03 https://t.co/vhrmtGTjw1 https://t.co/k1LLk95bv1
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×